Literature DB >> 8740851

Update of epidemiology, diagnosis, and treatment of pertussis.

J E Hoppe1.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8740851     DOI: 10.1007/bf01591352

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  41 in total

1.  Enrichment medium for the isolation of Bordetella.

Authors:  J Regan; F Lowe
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

2.  Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.

Authors:  J E Hoppe; A Eichhorn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

Review 3.  Antimicrobial susceptibility of Bordetella pertussis (Part I).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 Mar-Apr       Impact factor: 3.553

4.  Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis.

Authors:  J E Hoppe; T Tschirner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

5.  Whooping cough--aspects of pathogenesis and treatment.

Authors:  B Trollfors
Journal:  Acta Otolaryngol Suppl       Date:  1984

6.  The 1993 epidemic of pertussis in Cincinnati. Resurgence of disease in a highly immunized population of children.

Authors:  C D Christie; M L Marx; C D Marchant; S F Reising
Journal:  N Engl J Med       Date:  1994-07-07       Impact factor: 91.245

7.  Frequency of unrecognized Bordetella pertussis infections in adults.

Authors:  J G Deville; J D Cherry; P D Christenson; E Pineda; C T Leach; T L Kuhls; S Viker
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

8.  Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects.

Authors:  S O Bergquist; S Bernander; H Dahnsjö; B Sundelöf
Journal:  Pediatr Infect Dis J       Date:  1987-05       Impact factor: 2.129

9.  Prevention of secondary transmission of pertussis in households with early use of erythromycin.

Authors:  M A Sprauer; S L Cochi; E R Zell; R W Sutter; J R Mullen; S J Englender; P A Patriarca
Journal:  Am J Dis Child       Date:  1992-02

10.  Evaluation of pooled and individual components of Bordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis.

Authors:  Q He; J Mertsola; J P Himanen; O Ruuskanen; M K Viljanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

View more
  5 in total

Review 1.  State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.

Authors:  J E Hoppe
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

Review 2.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Polymorphism in the pertussis toxin promoter region affecting the DNA-based diagnosis of Bordetella infection.

Authors:  M Nygren; E Reizenstein; M Ronaghi; J Lundeberg
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 4.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

5.  Comparison of three media for agar dilution susceptibility testing of Bordetella pertussis using six antibiotics.

Authors:  J E Hoppe; T Paulus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.